The Louisville, CO-based company has raised $7.5 million and will use the new capital to help with regulatory approval and the commercial launch of the system.

Omar Ford

November 8, 2018

1 Min Read
Eximis Working on a New Surgical Platform

Eximis Surgical has secured $7.5 million in financing to help develop a surgical platform for the removal large specimens through small laparoscopic incisions. The financing was led by Questa Capital with participation from Venture Investors.

The Louisville, CO-based company said it will use the new capital to fund U.S. regulatory approval and the commercial launch of the Eximis Laparoscopic Specimen Removal System.

The firm said its platform uses specimen removal technique to have multiple, integrated containment bags for increased confidence and a novel cutting technology that eliminates the need for sharps during segmentation.

"I am extremely pleased with the investment by Questa Capital and Venture Investors, and I look forward to partnering as we approach regulatory submission and approval," Eximis Surgical co-founder and CEO, Kristin Johnson, said in a release. "Support from highly respected investors further validates our novel technology and enhances the capabilities of our experienced team."

About the Author(s)

Omar Ford

Omar Ford is MD+DI's Editor-in-Chief. You can reach him at [email protected].


Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like